Abstract
Gynostemma pentaphyllum is consumed as herbal tea by the Chinese. It has been extensively studied in the past 20 years and the major secondary metabolites, gypenosides (Gyp) are known to exhibit many medicinal properties such as anti-cancers, anti-inflammatory, antipyretic, anti-hyperlipidemic, and anti-diabetic. This review summarizes the effect of Gyp towards various cancer cells, and reports the five apoptotic pathways taken by Gyp in inhibiting the cancer cell growth and development, namely (1) blocking of cancer cell initiation, (2) apoptosis via Ca2+ overload, (3) causing mitochondrial membrane depolarization via caspase dependent and independent pathways, (4) inhibition of DNA repair genes by downregulation and (5) anti-metastatic effect by downregulating the synthesis of numerous tumor-associated metastatic-related proteins. Both in vitro and in vivo studies of Gyp showed that it could inhibit cancer cell growth and development. These results showed that Gyp has a great potential to be used as herbal remedy and an alternative treatment for cancer.
Similar content being viewed by others
Abbreviations
- AIF:
-
Apoptosis inducing factor
- Akt:
-
Alpha serine/threonine-protein kinase
- ATM:
-
Ataxia telangiectasia mutated
- ATR:
-
Ataxia-telangiectasia and Rad3-related
- BRCA1:
-
Breast cancer gene
- COX-2:
-
Cyclooxygenase-2
- DNAPK:
-
DNA-dependent serine/threonine protein kinase
- ECM:
-
Extracellular matrix
- Endo G:
-
Endonuclease G
- ER:
-
Endoplasmic reticulum
- ERK1/2:
-
Extracellular signal-regulated kinase 1/2
- FAK:
-
Focal adhesion kinase
- Gyp:
-
Gypenosides
- H2O2 :
-
Hydrogen peroxide
- IP3R:
-
Inositol 1,4,5-triphosphate receptors
- IR:
-
Ionizing
- MANA:
-
Methyl-n-amyl nitrosamine
- MMP-2:
-
Matrix metalloproteinase-2
- MMP-9:
-
Matrix metalloproteinase-9
- NF-κB:
-
Nuclear factor-kappa B
- ROS:
-
Reactive oxygen species
- SERCA:
-
Sarco/ER-Ca2+-ATPase
- SOS:
-
Sevenless homolog
- uPA:
-
Urokinase-type plasminogen activator
- UV:
-
Ultraviolet
References
Astin JA (1998) Why patients use alternative medicine: results of a national study. J Am Med Assoc 279(19):1548–1553
Bray F, Ren JS, Masuyer E, Ferlay J (2013) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132:1133–1145
Chen WC, Hau DM, Chen KT, Wang MI, Lin IH (1996) Protective effects of Gynostemma pentaphyllum in γ-irradiated mice. Am J Chin Med 24:83–92
Chen JC, Lu KW, Lee JH, Yeh CC, Chung JG (2006) Gypenosides induced apoptosis in human colon cancer cells through the mitochondria-dependent pathways and activation of caspase-3. Anticancer Res 26:4313–4326
Chen JC, Lu KW, Tsai ML, Hsu SC, Kuo CL, Yang JS, et al. (2009) Gypenosides induced G0/G1 arrest via CHk2 and apoptosis through endoplasmic reticulum stress and mitochondria-dependent pathways in human tongue cancer SCC-4 cells. Oral Oncol 45:273–283
Cheng TC, Lu JF, Wang JS, Lin LJ, Kuo HI, Chen BH (2011) Antiproliferation effect and apoptosis mechanism of prostate cancer cell PC-3 by flavonoids and saponins prepared from Gynostemma pentaphyllum. J Agric Food Chem 59:11319–11329
Colegate SM, Molyneux RJ (2007) Bioactive natural products: detection, isolation, and structural determination. CRC press, Boca Raton
Fidler IJ (2003) The pathogenesis of cancer metastasis: the'seed and soil'hypothesis revisited. Nat Rev Cancer 3:453–458
Haq I (2004) Review: safety of medicinal plants. Pak J Med Res 43:4
Hoareau L, DaDilva EJ (1999) Medicinal plants: a re-emerging health aid. Plant Biol 2(2):56–70
Hsiao W, Tai WCS, Mo Z, Wu PK (2008) The anticancer activities and the drug targets of botanical saponins from a medicinal herb, Gynostemma pentaphyllum. J Biotechnol 136:S22–S23
Hsu HY, Yang JS, Lu KW, Yu CS, Chou ST, Lin JJ, et al. (2011) An experimental study on the antileukemia effects of gypenosides in vitro and in vivo. Integr Cancer Ther 10:101–112
Huang TH-W, Li Y, Razmovski-Naumovski V, Li GQ, Duke CC, Roufogalis BD (2006) Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway. J Biomed Sci 13:535–548
Huyen V, Phan D, Thang P, Hoa N, Östenson C (2010) Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients. Horm Metab Res 42:353
Klein G (2004) Cancer, apoptosis, and nonimmune surveillance. Cell Death Differ 11:13–17
Kunapuli P, Kasyapa CS, Hawthorn L, Cowell JK (2004) LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway. J Biol Chem 279:23151–23157
Li L, Jiao LP, Lau BH (1993) Protective effect of gypenosides against oxidative stress in phagocytes, vascular endothelial cells and liver microsomes. Cancer Biother Radiopharm 8:263–272
Lin CC, Huang PC, Lin JM (2000) Antioxidant and hepatoprotective effects of Anoectochilus Formosanus and Gynostemma pentaphyllum. Am J Chin Med 28:87–96
Lin JJ, Hsu HY, Yang JS, Lu KW, Wu RSC, Wu KC, et al. (2011) Molecular evidence of anti-leukemia activity of gypenosides on human myeloid leukemia HL-60 cells in vitro and in vivo using a HL-60 cells murine xenograft model. Phytomedicine 18:1075–1085
Lu HF, Chen YS, Yang JS, Chen JC, Lu KW, Chiu TH, et al. (2008) Gypenosides induced G0/G1 arrest via inhibition of cyclin E and induction of apoptosis via activation of caspases-3 and-9 in human lung cancer A-549 cells. In Vivo 22:215–221
Lu KW, Chen JC, Lai TY, Yang JS, Weng SW, Ma YS, et al. (2010) Gypenosides causes DNA damage and inhibits expression of DNA repair genes of human oral cancer SAS cells. In Vivo 24:287–291
Lu KW, Chen JC, Lai TY, Yang JS, Weng SW, Ma YS, et al. (2011) Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2-9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways. Hum Exp Toxicol 30:406–415
Lu KW, Chen JC, Lai TY, Yang JS, Weng SW, Ma YS, Lin HY, Wu RSC, Wu KC, Wood W, et al. (2012) Gypenosides suppress growth of human oral cancer SAS cells in vitro and in a murine xenograft model: the role of apoptosis mediated by caspase-dependent and caspase-independent pathways. Integrative Cancer Therapies 11:129–140
Megalli S, Aktan F, Davies NM, Roufogalis BD (2005) Phytopreventative anti-hyperlipidemic effects of Gynostemma pentaphyllum in rats. J Pharm Pharm Sci 8:507–515
Megalli S, Davies NM, Roufogalis BD (2006) Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat. J Pharm Pharm Sci 9:281–291
Mendes O, Kim HT, Lungu G, Stoica G (2007) MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin Exp Metastasis 24:341–351
Mishra R, Joshi D. Jiao Gu Lan (Gynostemma pentaphyllum): The Chinese Rasayan-Current Research Scenario (2011) International Journal of Research In Pharmaceutical and Biomedical Science 2:1483.
Murata H, Kawano S, Tsuji S, Tsujii M, Sawaoka H, Kimura Y, et al. (1999) Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 94:451–455
Razmovski-Naumovski V, Huang TH-W, Li GQ, Duke CC, Roufogalis BD (2005) Chemistry and pharmacology of Gynostemma pentaphyllum. Phytochem Rev 4:197–219
Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comparehensive cancer center and the implications for oncology. J Clin Oncol 18(13):2505–2514
Schild L, Chen B, Makarov P, Kattengell K, Heinitz K, Keilhoff G (2010) Selective induction of apoptosis in glioma tumour cells by a Gynostemma pentaphyllum extract. Phytomedicine 17:589–597
Srivastava V, Negi AS, Kumar J, Gupta M, Khanuja SP (2005) Plant-based anticancer molecules: a chemical and biological profile of some important leads. Bioorg Med Chem 13:5892–5908
Sun DP, Li XX, Liu XL, Zhao D, Qiu FQ, Li Y, et al. (2013) Gypenosides induce apoptosis by Ca2+ overload mediated by endoplasmic-reticulum and store-operated Ca2+ channels in human hepatoma cells. Cancer Biother Radiopharm 28:320–326
Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, et al. (2000) Two distinct pathways leading to nuclear apoptosis. J Exp Med 192:571–580
Tanner MA, Bu X, Steimle JA, Myers PR (1999) The direct release of nitric oxide by gypenosides derived from the herb Gynostemma pentaphyllum. Nitric Oxide 3:359–365
Tsujii M, Kawano S, DuBois RN (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci 94:3336–3340
Verma S, Singh SP (2008) Current and future status of herbal medicines. Veterinary World 1(11):347–350
Wang Z, Luo D (2007) Antioxidant activities of different fractions of polysaccharide purified from Gynostemma pentaphyllum Makino. Carbohydr Polym 68:54–58
Wang C, Wang X, Li Y, Deng S, Jiang Y, Yue L (1995) A preliminary observation of preventive and blocking effect of Gynostemma pentaphyllum (Thunb) Makino on esophageal cancer in rats. Journal of West China University of Medical Sciences 26:430
Wang QF, Chen JC, Hsieh SJ, Cheng CC, Hsu SL (2002) Regulation of Bcl-2 family molecules and activation of caspase cascade involved in gypenosides-induced apoptosis in human hepatoma cells. Cancer Lett 183:169–178
Wang QF, Chiang CW, Wu CC, Cheng CC, Hsieh SJ, Chen JC, et al. (2007) Gypenosides induce apoptosis in human hepatoma huh-7 cells through a calcium/reactive oxygen species-dependent mitochondrial pathway. Planta Med 73:535–544
Xie Z, Liu W, Huang H, Slavin M, Zhao Y, Whent M, et al. (2010) Chemical composition of five commercial Gynostemma pentaphyllum samples and their radical scavenging, antiproliferative, and anti-inflammatory
Xu W, Towers AD, Li P, Collet JP (2006) Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care 15:397–403
Yates JS, Mustian KM, Morrow GR, Gillies LJ, Atkins JN, Kirshner JL, Colman LK (2005) Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 13:806–811
Yeo J, Kang YJ, Jeon SM, Jung UJ, Lee MK, Song H, et al. (2008) Potential hypoglycemic effect of an ethanol extract of Gynostemma pentaphyllum in C57BL/KsJ-db/db mice. J Med Food 11:709–716
Zhang X, Liu S, Hu T, Liu S, He Y, Sun S (2009) Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50:490–499
Zhou Z, Xu W, Zhang S, Zhou Y, Jin Z, Wang Z, et al. (1997) The study of influencing cellular dynamics of Gynostemma pentaphyllum on golden hamster cheek pouch premalignancy. Shanghai Journal of Stomatology 6:65
Zhu H, Liu Z, Tang L, Liu J, Zhou M, Xie F, et al. (2012) Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells. Eur J Pharmacol 696:43–53
Acknowledgments
The authors would like to thank Prof Basil for the permission to reuse the table, Elsevier and John and Wiley and Sons for the license for the figures. The authors would like to thank UCSI University for scientific databases access for the literatures used in the review paper.
Authors’ contributions
YLC wrote the manuscript; HCW critically revised the manuscript. Both authors have read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical statements
No ethical issue involved in this review.
Conflict of Interest
The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Chew, YL., Wong, HC. Gypenosides, the cancer buster from Gynostemma pentaphyllum (Thunb.) Makino and the apoptotic pathways: a review. Orient Pharm Exp Med 16, 153–164 (2016). https://doi.org/10.1007/s13596-016-0231-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13596-016-0231-0